Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros

Métodos Terapêuticos e Terapias MTCI
Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
Georgian Med News ; (Issue): 12-16, 2016 Nov.
Artigo em Russo | MEDLINE | ID: mdl-28009309

RESUMO

The article presents the analysis of the intensive therapy through the correction of persistent hypernatremia in neurosurgical patients after removal of brain tumors. The aim of this work was to evaluate the effectiveness of Sterofundin in the framework of complex therapy of hypernatremia in neurosurgical patients after removal of brain tumors. We analyzed the dynamics of the concentrations of sodium, potassium, chorus of the plasma, anion gap and buffer bases in the postoperative period of these patients. For obtaining reliable results, the patients were divided into groups according to the nature of the treatment: Sterofundin and symptomatic correction of hypotonic solution of sodium chloride, saluretic and Verospiron respectively. In a comparison between the groups, a distinct difference in the speed of regression of hypernatremia and durability of the achieved effect was observed. In case of treatment with Sterofundin there was a significant decrease of hypernatremia by the end of the second day of the postoperative period without tendency to re-raise. The prevalence of hypotonic solutions of sodium chloride and potassium-sparing saluretics in intensive care allowed reducing the sodium concentration non-persistently to the fourth day on the background of significant fluctuations in its concentration. The use of Sterofundin in complex therapy of electrolyte disturbances, particularly of hypernatremia in neurosurgical patients after removal of brain tumors, is reflected in the form of significant regression of increased sodium concentration in plasma compared with the method of use "hypotonic" hemodilution, saluretics and potassium-sparing diuretics.


Assuntos
Adenoma/metabolismo , Neoplasias Encefálicas/metabolismo , Hipernatremia/tratamento farmacológico , Complicações Pós-Operatórias/tratamento farmacológico , Desequilíbrio Ácido-Base/tratamento farmacológico , Desequilíbrio Ácido-Base/etiologia , Adenoma/patologia , Adenoma/cirurgia , Adulto , Neoplasias Encefálicas/patologia , Neoplasias Encefálicas/cirurgia , Feminino , Humanos , Hipernatremia/etiologia , Hipotálamo/patologia , Masculino , Procedimentos Neurocirúrgicos/efeitos adversos , Compostos Orgânicos/uso terapêutico , Hipófise/patologia , Complicações Pós-Operatórias/etiologia , Estudos Retrospectivos , Desequilíbrio Hidroeletrolítico/tratamento farmacológico , Desequilíbrio Hidroeletrolítico/etiologia
2.
Poult Sci ; 90(1): 157-67, 2011 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-21177455

RESUMO

Exposing broilers to a high temperature increases water and electrolyte K(+) and Na(+) excretion, which negatively affects the heat dissipation capacity and acid-base homeostasis, resulting in losses in growth performance. In this experiment, the efficacy of providing oral rehydration therapy and betaine on growth performance, acid-base balance, and water and electrolyte retention was evaluated. A total of 432 one-day-old broiler chicks (Cobb) were allocated to 72 metabolic cages and reared to 31 d of age under standard conditions. From 32 to 41 d of age, chicks were exposed to heat stress (ambient temperature, 32°C) and high RH (80 to 100% RH) for 9 h daily. The ameliorative effects of a 3 × 3 factorial array of treatments administered via drinking water were evaluated in 8 replicates of 6 chicks per cage for each treatment. Two oral rehydration therapy (ORT) fluids, based on either citrate or bicarbonate salts, were added to tap water. In addition, betaine was added to tap water at an inclusion rate of 0, 500, or 1,000 mg/L to complete the array of 9 liquid-based treatments. Growth performance was assessed at 32, 35, and 41 d of age. From 32 to 35 d of age, chicks receiving ORT fluids exhibited improved growth performance, water balance, and electrolyte (K(+), Na(+)) retention. In addition, the physiological response to stress was attenuated, as indicated by lower heterophil-to-lymphocyte ratios and blood glucose concentrations relative to the negative controls. The addition of betaine at an inclusion rate of 500 mg/L improved BW gain. From d 36 to 41, treatments did not significantly influence growth performance, which suggests that chicks receiving tap water were able to compensate and adapt to the heat-stress conditions. The results demonstrate that the beneficial effects of providing ORT fluids and 500 mg of betaine/L were observed only during the first 4 d of heat exposure. After this period, adaptation to the heat appears to occur, and none of the treatments was successful in improving growth performance.


Assuntos
Desequilíbrio Ácido-Base/tratamento farmacológico , Betaína/farmacologia , Galinhas , Hidratação/veterinária , Doenças das Aves Domésticas/tratamento farmacológico , Água/administração & dosagem , Animais , Betaína/administração & dosagem , Suplementos Nutricionais , Temperatura Alta , Masculino , Estresse Fisiológico/efeitos dos fármacos
4.
Z Kardiol ; 74 Suppl 2: 109-14, 1985.
Artigo em Inglês | MEDLINE | ID: mdl-4002783

RESUMO

27 patients with creatinine clearances ranging from 20 to 2 ml/min were treated daily with 6.9 mg/kg of muzolimine, for 10 to 25 days. The hyperhydration state with oedema decreased gradually in all patients without hypotensive phenomena. Muzolimine benefited hypertension in patients with expansion of the extracellular space and it also strengthened the effect of clonidine or minoxidil. Important diuretic and natriuretic effects were obtained. Metabolic acidosis improved. No subjective adverse reactions to the drug or side effects were noted. High-dose muzolimine appears to be efficacious and safe for short-term treatment in patients with severe chronic renal failure.


Assuntos
Falência Renal Crônica/tratamento farmacológico , Muzolimina/uso terapêutico , Pirazóis/uso terapêutico , Desequilíbrio Ácido-Base/tratamento farmacológico , Acidose/tratamento farmacológico , Adulto , Idoso , Clonidina/uso terapêutico , Diurese/efeitos dos fármacos , Edema/tratamento farmacológico , Feminino , Taxa de Filtração Glomerular , Humanos , Hipertensão/tratamento farmacológico , Falência Renal Crônica/fisiopatologia , Masculino , Pessoa de Meia-Idade , Muzolimina/efeitos adversos , Natriurese/efeitos dos fármacos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA